【研究名】Bolus-pCINC 重炭酸ナトリウムボーラス投与を用いた緊急経皮的冠動脈形成術後の造影剤腎症予防効果に関する臨床研究
【プロトコル論文】 Prevention of Contrast-Induced Nephropathy After Emergency Percutaneous Coronary Intervention With a Single Bolus Administration of High-Concentrate Sodium Bicarbonate ― Rationale and Design of a Single-Arm Study Compared With Historical Controls ―
Circulation Reports.doi:10.1253/circrep.CR-22-0105
【研究名】BIGSTEP Study 糖化ヘスペリジンの原発性胆汁性胆管炎患者に対する有効性と安全性についての研究
【プロトコル論文】 Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study.
Medicine (Baltimore). 2022 Dec 2;101(48):e32127. doi:10.1097/MD.0000000000032127
【研究名】FRAT Study 脳血管障害患者に対する機能的電気刺激を応用したリハビリテーション治療試験
【プロトコル論文】 Feasibility and acceptability of novel functional electronic stimulated rehabilitation application for treatment in patients with cerebrovascular disorders: the FRAT study protocol
Pilot Feasibility Stud. 2022 Dec 14;8(1):258. doi:10.1186/s40814-022-01217-7
【研究名】NOLDOR Study ロボット支援腹腔鏡下前立腺全摘除術における目標指向型鎮痛管理がレミフェンタニル使用量に与える影響-無作為化比較試験-
【プロトコル論文】 Effect of NOciception Level-Directed analgesic management on Opioid usage in Robot-assisted laparoscopic radical prostatectomy (NOLDOR): study protocol for a single-centre single-blinded randomised controlled trial
BJA Open Volume 4, December 2022, 100112. doi:10.1016/j.bjao.2022.100112
【研究名】UNEBI Study インヒビター保有血友病A患者を対象とした、エミシズマブ投与下における破綻出血時/手術時止血管理におけるバイパス製剤投与時の凝固能測定に関する研究
【プロトコル論文】 Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial
BMJ Open 2022 Feb 17;12(2):e056922. doi: 10.1136/bmjopen-2021-056922
【研究名】ZEAL パーキンソン病の睡眠異常に対するゾニサミド（トレリーフ）の有効性に関するプラセボ対照、無作為化単盲検比較試験
【プロトコル論文】 Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials
Front Neurol. 2021 Dec 10;12:741307. doi: 10.3389/fneur.2021.741307. eCollection 2021.
【研究名】TARGET-UA 高尿酸血症を合併した慢性腎臓病患者に対する積極的尿酸降下療法の有効性を検証するランダム化比較試験 Trial of intensive UA-lowering therapy in CKD patients
【プロトコル論文】 Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial
Clin Exp Nephrol. 2020 Mar;24(3):235-241. doi: 10.1007/s10157-019-01815-5. Epub 2019 Nov 15. PMID: 31729647 DOI: 10.1007/s10157-019-01815-5
【研究名】CANTABILE DPP-4阻害薬およびSGLT2阻害薬が2型糖尿病患者におけるメタボリックリスク因子に与える効果 Comparison of canagliflozin vs. tenegliptin against basic metabolic risks in patients with type 2 diabetes mellitus
【プロトコル論文】 Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial
Diabetes Ther. 2020 Jan;11(1):347-358. doi: 10.1007/s13300-019-00717-9. Epub 2019 Nov 1. PMID: 31677134 PMCID: PMC6965530 DOI: 10.1007/s13300-019-00717-9
DOI: https://doi.org/10.1007/s13300-019-00717-9
【本論文】Comparison of efficacy between dipeptidyl peptidase-4 inhibitor and sodium–glucose cotransporter 2 inhibitor on metabolic risk factors in Japanese patients with type 2 diabetes mellitus: Results from the CANTABILE study
Diabetes Res Clin Pract. 2021 Oct;180:109037. doi: 10.1016/j.diabres.2021.109037. Epub 2021 Sep 2.
【研究名】CANONICAL 左室収縮性が保持された心不全合併高齢2型糖尿病患者におけるSGLT2阻害薬カナグリフロジンの有効性・安全性に及ぼす影響 Canagliflozin heart failure with preserved ejection fraction study in type 2 diabetes mellitus
【プロトコル論文】 Rationale and Design of the CANONICAL Study ― Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Canagliflozin for Heart Failure With Preserved Ejection Fraction With Type 2 Diabetes Mellitus ―
Circ Rep. 2019 Aug 3;1(8):347-351. doi: 10.1253/circrep.CR-19-0049. PMID: 33693161 PMCID: PMC7892479 DOI: 10.1253/circrep.CR-19-0049
DOI: https://doi.org/10.1253/circrep.CR-19-0049
【本論文】Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes
Circulation Reports.CircRep2021;3: 440 – 448. doi: 10.1253/circrep.CR-21-0030
